Pulmonologists at NewYork-Presbyterian/Weill Cornell Medical Center are developing a new paradigm to confront idiopathic pulmonary fibrosis (IPF) and other forms of progressive fibrotic ILDs.

Dr. Garcia’s research utilizes next generation sequencing and bioinformatic analyses to identify rare mutations in genes linked to inherited forms of lung disease.

Researchers Kenneth Wengler, PhD and Guillermo Horga, MD, PhD have found evidence of a potential neurobiological mechanism for hallucinations and delusions that fit within the hierarchical model of psychosis and can explain their clinical presentation.

A study by investigators at Weill Cornell Medicine, NewYork-Presbyterian, and Yale University demonstrates that safety signals activate different circuits in the brain from those involved in typical anxiety therapy.

In May 2021, Vivian B. Pender, MD, Clinical Professor of Psychiatry at Weill Cornell Medicine and Lecturer in Psychoanalysis at Columbia University Vagelos College of Physicians and Surgeon, will assume the role as President of the American Psychiatric Association (APA).

The new clinical integration system at New York-Presbyterian/Weill Cornell Medical Center’s level IV neonatal intensive care unit (NICU) is ringing all the right alarms.

Critically-ill, preterm infants with rare, genetic diseases are a notoriously difficult group to diagnose. Genome-wide testing during the newborn period may have a profound impact on clinical decision-making, which may make all the difference for a family with a sick baby.

PCOS is a particular clinical and research focus of Sharon E. Oberfield, MD, Chief of the Division of Pediatric Endocrinology, Diabetes, and Metabolism, Aviva B. Sopher, MD, MS, a pediatric endocrinologist at NewYork-Presbyterian/Columbia University Irving Medical Center.